Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
363.16 USD | +1.67% | +1.84% | +34.17% |
Oct. 28 | TD Cowen Adjusts HCA Healthcare's Price Target to $440 From $450, Keeps Buy Rating | MT |
Oct. 28 | KeyBanc Adjusts HCA Healthcare's Price Target to $420 From $475, Keeps Overweight Rating | MT |
Capitalization | 90.48B | P/E ratio 2024 * |
16.1x | P/E ratio 2025 * | 14.5x |
---|---|---|---|---|---|
Enterprise value | 131B | EV / Sales 2024 * |
1.85x | EV / Sales 2025 * | 1.76x |
Free-Float |
71.59% | Yield 2024 * |
0.74% | Yield 2025 * | 0.77% |
Last Transcript: HCA Healthcare, Inc.
1 day | +1.67% | ||
1 week | -0.11% | ||
Current month | +1.23% | ||
1 month | -7.47% | ||
3 months | +1.91% | ||
6 months | +18.00% | ||
Current year | +34.17% |
Director | Title | Age | Since |
---|---|---|---|
Samuel Hazen
CEO | Chief Executive Officer | 63 | 2018-12-31 |
Mike Marks
DFI | Director of Finance/CFO | 54 | 2024-04-30 |
Randy Fagin
CTO | Chief Tech/Sci/R&D Officer | - | - |
Manager | Title | Age | Since |
---|---|---|---|
Thomas Frist
CHM | Chairman | 56 | 2019-04-25 |
William Frist
BRD | Director/Board Member | 54 | 2008-12-31 |
Samuel Hazen
BRD | Director/Board Member | 63 | 2018-09-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.96% | 7 M€ | +8.15% | ||
1.88% | 19 M€ | +10.60% | - |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
+1.67% | -0.11% | +57.32% | +45.26% | 90.48B | ||
-2.08% | -3.26% | -22.21% | -43.27% | 70.21B | ||
-0.49% | -2.31% | +11.93% | +64.94% | 26.88B | ||
-2.09% | -1.86% | +31.29% | -14.39% | 20.74B | ||
+0.03% | -0.64% | +8.06% | -20.98% | 18.99B | ||
-0.62% | -0.46% | +15.25% | +6.41% | 17.33B | ||
-0.58% | +4.90% | +188.82% | +10.30% | 15.36B | ||
+4.00% | +16.18% | +195.67% | +120.39% | 14.85B | ||
+1.74% | +3.00% | +62.83% | +67.28% | 13.69B | ||
+3.05% | +10.63% | +79.33% | +203.30% | 11.64B | ||
Average | +0.80% | +2.08% | +62.83% | +43.92% | 30.02B | |
Weighted average by Cap. | +0.94% | +0.21% | +41.99% | +24.82% |
Financials
(USD)2024 * | 2025 * | |
---|---|---|
Net sales | 70.67B | 74.78B |
Net income | 5.84B | 6.24B |
Net Debt | 40.25B | 40.84B |
Date | Price | Change | Volume |
---|---|---|---|
24-11-04 | 363.16 $ | +1.67% | 1,547,716 |
24-11-01 | 357.19 $ | -0.43% | 1,317,726 |
24-10-31 | 358.74 $ | -0.60% | 1,188,214 |
24-10-30 | 360.92 $ | +0.07% | 1,266,664 |
24-10-29 | 360.67 $ | +1.14% | 1,640,148 |
Delayed Quote Nyse, November 04, 2024 at 04:00 pm EST
More quotesQuarterly revenue - Rate of surprise
- Stock Market
- Equities
- HCA Stock